栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/05/11 | 1,823 | 1,842 | 1,800 | 1,840 | +21 | +1.2% | 456,700 |
2020/05/08 | 1,888 | 1,897 | 1,793 | 1,819 | -82 | -4.3% | 751,800 |
2020/05/07 | 1,840 | 1,914 | 1,840 | 1,901 | +51 | +2.8% | 522,900 |
2020/05/01 | 1,861 | 1,871 | 1,838 | 1,850 | -33 | -1.8% | 433,900 |
2020/04/30 | 1,967 | 2,013 | 1,865 | 1,883 | -132 | -6.6% | 1,331,100 |
2020/04/28 | 2,035 | 2,038 | 1,989 | 2,015 | +12 | +0.6% | 355,300 |
2020/04/27 | 1,978 | 2,015 | 1,967 | 2,003 | +49 | +2.5% | 442,400 |
2020/04/24 | 1,980 | 1,991 | 1,933 | 1,954 | -37 | -1.9% | 446,900 |
2020/04/23 | 1,970 | 1,991 | 1,957 | 1,991 | +15 | +0.8% | 431,200 |
2020/04/22 | 1,951 | 1,982 | 1,889 | 1,976 | -15 | -0.8% | 774,300 |
2020/04/21 | 2,015 | 2,024 | 1,978 | 1,991 | -66 | -3.2% | 459,500 |
2020/04/20 | 2,075 | 2,090 | 2,046 | 2,057 | +1 | ±0% | 492,600 |
2020/04/17 | 2,119 | 2,125 | 2,021 | 2,056 | -64 | -3% | 750,000 |
2020/04/16 | 2,080 | 2,120 | 2,060 | 2,120 | +33 | +1.6% | 407,100 |
2020/04/15 | 2,129 | 2,129 | 2,045 | 2,087 | -54 | -2.5% | 551,600 |
2020/04/14 | 2,122 | 2,155 | 2,112 | 2,141 | -9 | -0.4% | 388,900 |
2020/04/13 | 2,157 | 2,170 | 2,112 | 2,150 | +6 | +0.3% | 499,000 |
2020/04/10 | 2,110 | 2,155 | 2,084 | 2,144 | +84 | +4.1% | 1,064,700 |
2020/04/09 | 2,069 | 2,085 | 2,028 | 2,060 | -5 | -0.2% | 553,900 |
2020/04/08 | 2,041 | 2,097 | 2,036 | 2,065 | +4 | +0.2% | 519,000 |
2020/04/07 | 2,099 | 2,121 | 2,011 | 2,061 | -10 | -0.5% | 491,600 |
2020/04/06 | 2,006 | 2,077 | 1,972 | 2,071 | +111 | +5.7% | 687,500 |
2020/04/03 | 2,065 | 2,099 | 1,941 | 1,960 | -87 | -4.3% | 566,100 |
2020/04/02 | 1,954 | 2,096 | 1,954 | 2,047 | +84 | +4.3% | 981,600 |
2020/04/01 | 2,050 | 2,110 | 1,951 | 1,963 | -8 | -0.4% | 1,551,100 |
2020/03/31 | 1,997 | 2,025 | 1,951 | 1,971 | -40 | -2% | 517,000 |
2020/03/30 | 1,883 | 2,014 | 1,855 | 2,011 | +156 | +8.4% | 822,900 |
2020/03/27 | 1,850 | 1,883 | 1,813 | 1,855 | +38 | +2.1% | 663,000 |
2020/03/26 | 1,782 | 1,845 | 1,756 | 1,817 | -13 | -0.7% | 508,100 |
2020/03/25 | 1,824 | 1,835 | 1,762 | 1,830 | +55 | +3.1% | 571,000 |
2020/03/24 | 1,800 | 1,805 | 1,726 | 1,775 | +4 | +0.2% | 522,600 |
2020/03/23 | 1,867 | 1,876 | 1,703 | 1,771 | -56 | -3.1% | 1,020,700 |
2020/03/19 | 1,935 | 1,998 | 1,781 | 1,827 | +172 | +10.4% | 2,379,400 |
2020/03/18 | 1,636 | 1,712 | 1,581 | 1,655 | +32 | +2% | 558,400 |
2020/03/17 | 1,479 | 1,637 | 1,440 | 1,623 | +121 | +8.1% | 718,500 |
2020/03/16 | 1,617 | 1,673 | 1,492 | 1,502 | -94 | -5.9% | 699,400 |
2020/03/13 | 1,520 | 1,631 | 1,475 | 1,596 | -61 | -3.7% | 631,200 |
2020/03/12 | 1,686 | 1,749 | 1,639 | 1,657 | -69 | -4% | 501,000 |
2020/03/11 | 1,807 | 1,838 | 1,722 | 1,726 | -74 | -4.1% | 542,800 |
2020/03/10 | 1,667 | 1,821 | 1,625 | 1,800 | +28 | +1.6% | 729,600 |
2020/03/09 | 1,855 | 1,880 | 1,751 | 1,772 | -176 | -9% | 635,400 |
2020/03/06 | 1,970 | 2,018 | 1,940 | 1,948 | -56 | -2.8% | 383,500 |
2020/03/05 | 2,028 | 2,038 | 1,982 | 2,004 | +10 | +0.5% | 335,700 |
2020/03/04 | 1,972 | 2,060 | 1,957 | 1,994 | -22 | -1.1% | 523,700 |
2020/03/03 | 2,050 | 2,120 | 2,000 | 2,016 | -6 | -0.3% | 851,200 |
2020/03/02 | 1,998 | 2,065 | 1,935 | 2,022 | +125 | +6.6% | 1,278,200 |
2020/02/28 | 1,971 | 1,996 | 1,882 | 1,897 | -159 | -7.7% | 992,500 |
2020/02/27 | 2,088 | 2,130 | 2,045 | 2,056 | -64 | -3% | 759,200 |
2020/02/26 | 2,224 | 2,245 | 2,058 | 2,120 | -126 | -5.6% | 1,235,900 |
2020/02/25 | 2,196 | 2,290 | 2,150 | 2,246 | +6 | +0.3% | 1,107,900 |
1101~
1150
件表示中 / 6826件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 232,200円 | +0.4% | -8.4% | 2.28% | 30.69倍 | 1.75倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 121,300円 | +197.7% | - | 0.00% | 49.57倍 | 1.58倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 151,800円 | +3.2% | +4.5% | 3.43% | 17.44倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 67,900円 | -3.7% | -36.7% | 2.95% | 23.03倍 | 1.50倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 101,300円 | - | - | 0.00% | - | 51.01倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム